Drug Database
Back to search

Netherlands· NL-a6f67aecc038

Cibinqo 50 mg, filmomhulde tabletten

A abrocitinib product containing abrocitinib, registered in Netherlands by Pfizer Europe MA EEIG. The same ATC class is registered in 15 of our 19 countries.

ATC D11AH08

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCibinqo 50 mg, filmomhulde tablettenATCD11AH08REGISTER NO.NL-a6f67aecc038PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about abrocitinibAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Abrocitinib is registered in 15 of 19 countries.

Countries holding a registration under ATC D11AH08 (abrocitinib), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose
Search abrocitinib products by name

Abrocitinib · ATC D11AH08

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of abrocitinib costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.26 in France to $295.64 in United States — a ×1143 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Abrocitinib · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

  • US United States$295.64 (acquisition cost)
  • CH Switzerland$122.11
  • FR France$0.26
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ABROCITINIB
Manufacturer
Pfizer Europe MA EEIG
Country
Netherlands (NL)
ATC code
D11AH08
ATC class
Abrocitinib
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/21/1593

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Abrocitinib in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All abrocitinib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Cibinqo
  • Liechtenstein · Cibinqo
  • Norway · Cibinqo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5567e44f-4a14-430d-b9ca-603baa514ef5
GET /v1/drugs/5567e44f-4a14-430d-b9ca-603baa514ef5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/cibinqo-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Abrocitinib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp127278",
  "excipients": [
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ABROCITINIB"
  ],
  "leaflet_url": null,
  "authorised_at": "2021/12/10",
  "procedure_number": "EMEA/H/C/005452",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/21/1593",
  "additional_monitoring": "Y"
}
API referenceMCP serverPlans

See everything about abrocitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console